FDA WARNS KOS ABOUT QUALITY SYSTEM DEFICIENCIES

Drug Industry Daily
KEYWORDS FDA / Warning
A A

The FDA has sent Kos Pharmaceuticals a warning letter citing quality system deficiencies observed during an inspection of the drugmaker's main manufacturing facility, the company announced Monday.

To View This Article:

Login

Subscribe To Drug Industry Daily